Feature | Dave Fornell
In the current era of healthcare reform with the overarching goal of reducing healthcare costs, heart failure (HF) management has taken center stage. It is the leading cause of hospitalization for adults over the age of 65 in the United States and accounts for more than 1 million hospitalizations annually, with Medicare expenditures of more than $17 billion.[1,2] It is apparent that current HF monitoring efforts are not adequate, which has led to great interest in more effective technologies.
July 09, 2014
Feature
A big fly in the ointment for widespread adoption of many new technologies is cost. In today’s cost-conscience environment of healthcare reform, there needs to be a clear, quantifiable return of investment (ROI).
July 09, 2014
Case Study | Atman P. Shah, M.D. and Sandeep Nathan, M.D., The University of Chicago
Mr. KH is a 58-year-old male with a past medical history of hypertension and tobacco abuse who presented to the emergency department (ED) with an episode of syncope. The patient stated that he was at home walking to the kitchen when he felt light-headed and then woke up on the floor. The event was witnessed by his wife, and he was not noted to have any seizure-like activity. On arrival in the ED, the patient began to complain of chest discomfort and dyspnea. A stat electrocardiogram (ECG) revealed sinus rhythm and 2 mm ST-segment depression in leads V4-V6. The patient lost consciousness while in the ED and was emergently intubated. His blood pressure was 65/45, and he was started on intravenous phenylephrine, dopamine and norepinephrine to maintain a blood pressure of 70/40. The patient was taken emergently to the cardiac catheterization laboratory (CCL) where an intra-aortic balloon pump (IABP), was emergently placed. Coronary angiography revealed mild atherosclerotic disease and the aortic valve could not be crossed.
July 09, 2014Sponsored Content
Feature | Information Technology
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
March 21, 2024News
July 8, 2014 — NorthStar Medical Radioisotopes LLC has signed a pledge with the Preparatory Commission for the Comprehensive Nuclear-Test-Ban Treaty Organization (CTBTO), designed to help the CTBTO detect nuclear testing.
July 08, 2014
News
July 8, 2014 — A Huntington Memorial Hospital patient has become the first patient in the San Gabriel Valley in southern California to be implanted with a tiny, leadless cardiac pacemaker. Developed for patients with bradycardia, St. Jude Medical’s Nanostim device is designed to be placed directly in a patient’s heart without the visible lump, scar and insulated wires (leads) required for conventional pacemakers.
July 08, 2014
News
July 8, 2014 — Humana Inc. announced earlier this year an expanded coverage policy for cardiac CT (computed tomography). Many of the new Humana indications have long been advocated for by the Society of Cardiovascular Computed Tomography (SCCT) and described in the model local coverage determination policy (LCD) developed by the organization.
July 08, 2014Sponsored Content
Feature | Cardiac Imaging
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
March 05, 2024News
Use of catheter ablation is not only beneficial for treating atrial flutter but also can significantly reduce hospital visits — both inpatient and emergency — and lower the risk for atrial fibrillation, according to research by the University of California San Francisco (UCSF).
July 08, 2014News
CardiAQ Valve Technologies (CardiAQ), a leader in the field of transcatheter mitral valve implantation (TMVI), announced that the European Patent Office Legal Division issued a temporary stay of further proceedings in Neovasc’s pending European patent application covering TMVI technology.
July 08, 2014News
Thoratec Corp. has acquired Apica Cardiovascular Ltd. for an upfront cash payment of $35 million and potential future clinical and sales milestones of up to $40 million.
July 07, 2014Sponsored Content
Blog
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
December 11, 2023
Technology
Vital Connect announced its HealthPatch MD biosensor has received U.S. Food and Drug Administration (FDA) clearance. The solution is capable of capturing clinical-grade biometric measurements and is the first FDA-cleared medical device that includes a fall detection feature.
July 07, 2014
News
Corindus Vascular Robotics has been named the recipient of the 2014 North American New Product Innovation Award in Interventional Cardiology, which was established by Frost & Sullivan to recognize visionary innovation and product excellence.
July 07, 2014
Technology
Vital Images Inc. announced the global release of VitreaExtend, an advanced visualization solution that supports up to three simultaneous users with high performance similar to Vital's advanced server-based solution.
July 07, 2014Sponsored Content
Case Study | Hemodynamic Monitoring Systems
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
November 14, 2023
Videos | Cardiovascular Ultrasound
DAIC Editor Dave Fornell highlights his choices for some of the most innovative new technology at the American Society ...
July 03, 2014
Feature
First Patient Enrolled in Study to Detect, Treat Vulnerable Plaques Suspected to Cause Heart Attacks
Infraredx Inc. announced the first patient enrolled in PROSPECT II, a multi-center, prospective study designed to assess the ability of intravascular imaging to identify non-flow obstructing vulnerable plaques.
July 03, 2014News
Mount Sinai Heart at Icahn School of Medicine at Mount Sinai has created an innovative Center for Medical Devices (CMeD) to advance the field of cardiovascular medicine and accelerate the delivery of promising medical devices to cardiac patients.
July 03, 2014© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now